TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04091633

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: WHO School Mental Health Program
Description: World Health Organization (WHO) School Mental Health Program (SMHP) is a manual based multi-component, multi-tiered and evidence-informed intervention for common mental health problems in school going children. SMHP is designed to be introduced into the normal classroom and school setting by trained teachers. The intervention has a universal component which takes a whole school approach that aims to promote mental health among all school children. It includes basic counseling skills for teachers, core values of mental health promoting schools and other health promoting efforts that impact upon mental health and can be administered to all students in school and classroom settings. The manual also contains targeted intervention strategies on anxiety, separation anxiety/ school refusal, post-trauma, depression, suicide, ADHD, autism, psychosis, conduct problems and substance use problems that can be implemented by teachers in classroom settings.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced School Mental Health Program (eSMHP)
Description: Informed by the results of pilot implementation, a number of content and delivery adaptations have been made to the School Mental Health Program (SMHP) to address the implementation challenges to scale-up of program in Pakistan. The adapted version of the intervention is called Enhanced School Mental Health Program (eSMHP). Enhancements to conventional SMHP have occurred at two levels: A) Content enhancements, such as a collaborative care model for engaging parents/primary caregivers, strategies for teacher's well-being, and adaptation and operationalization of particular clinical intervention strategies and B) Technological enhancements which include adaptation of the training manual for delivery using an online training platform, and a 'Chat-bot' to aid the implementation of intervention strategies in classroom settings.
Study: NCT03740971

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning treatment
Description: Remote Ischemic Conditioning is given twice a day with 200mmHg pressure.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Guideline-based therapy
Description: Guideline-based therapy
Study: NCT01783327

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teens-Connect
Description: Teens-Connect combines Managing Diabetes and TEENCOPE. Managing Diabetes consists of 5 sessions on age-appropriate, educational content related to diabetes problem-solving and self-efficacy to improve self-management. TEENCOPE consists of 5 sessions designed to increase youth's sense of competence and mastery by retraining inappropriate or non-constructive coping styles and forming more positive styles and patterns of behavior. The program is highly interactive and youth can talk with each other on an online moderated discussion board. Youth will be asked to use the website at least twice per week for 4 weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Planet D
Description: Planet D provides age-appropriate diabetes education on a variety of topics and social networking discussion boards on diabetes, food and exercise, personal interests, and diabetes camp. Planet D addresses emotions and self-management through education and social networking. Youth who register can also create a profile, upload and share pictures, identify favorite news and blog feeds as well as provide comments or tags to other members. Planet D has been online since 2007 and contains numerous diabetes-related articles geared toward youth as well as a secure message board. Youth will be asked to interact with the website twice a week for 4 weeks.
Study: NCT04145011

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cooled Radiofrequency
Description: Delivery of energy to ablate sensory nerves via cooled radiofrequency probe (18g, 4mm active tip)

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Radiofrequency
Description: Delivery of energy to ablate sensory nerves via non-cooled standard radiofrequency probe (22g, curved 10mm active tip)
Study: NCT01883635

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Survivor-only progressive walking and resistance exercise
Description: Daily, home-based, tailored exercise program delivered over the course of 6 weeks to the survivor only

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dyadic progressive walking and resistance exercise
Description: Daily, home-based, tailored exercise program delivered over the course of 6 weeks to the survivor and caregiver as a dyad
Study: NCT02072811

Intervention type: DRUG
Group type: OTHER
Intervention: DAC
Description: * DNR 60 mg/m2 0,5h infusion iv on 1-3 days~* 2-CdA 5 mg/m2 2h. infusion iv on 1-5 days~* Ara-C 200 mg/m2 12h infusion iv 2h after end of infusion with 2CdA on 1-7 days

Intervention type: DRUG
Group type: OTHER
Intervention: CLAG
Description: * G-CSF 30MU sc, on 0-5 days~* Mitoxantrone 10mg/m2 30 min infusion iv, on 1-3 days~* Cladribine 5mg/m2 in 2h infusion iv, on 1-5 days~* Ara-C 2000mg/m2 4h infusion iv, infusion start after 2h of Cladribine infusion end, on 1-5 day

Intervention type: DRUG
Group type: OTHER
Intervention: Consolidation, I HAM cycle
Description: * Ara-C 3g/m2; 3h infusion iv every 12h on 1,2,3 days~* Mitoxantrone 10mg/m2; 0,5h infusion iv on 3,4,5 days

Intervention type: DRUG
Group type: OTHER
Intervention: II Consolidation HiDAraC
Description: • Ara-C 3g/m2 every 12h; 3h infusion iv on 1,3,5 days (+ mobilization of CD34+)

Intervention type: DRUG
Group type: OTHER
Intervention: Consolidation, III HiDAraC cycle
Description: * Ara-C 3g/m2 every 12h; 3h infusion iv on 1,3,5 days~* 2-CdA 5 mg/m2 2h infusion iv on 1,3,5 days, 2h before Ara-C
Study: NCT06454253

Intervention type: DEVICE
Intervention: Da Vinci Robot Surgical System
Description: Performing surgery on right colon cancer patients using the da Vinci robotic surgical system or laparoscopic surgical system

Intervention type: DEVICE
Intervention: Da Vinci Robot Surgical System
Description: Performing surgery on right colon cancer patients using the da Vinci robotic surgical system or laparoscopic surgical system
Study: NCT03826550

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac Sodium Gel
Description: Twice daily for 60 days. Each patient is expected to receive 120 doses

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Solaraze 3% Topical Gel
Description: Twice daily for 60 days. Each patient is expected to receive 120 doses

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Twice daily for 60 days. Each patient is expected to receive 120 doses
Study: NCT01383837

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STYLEnS
Description: Multifamily group HIV/STI Prevention Intervention or Single Family Dyad (youth and a parent)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Promotion
Description: Health Promotion Intervention
Study: NCT01086800

Intervention type: OTHER
Group type: OTHER
Intervention: Healthy Lifestyles and Sleep Education plus PAP
Description: Participants randomized to this arm will be educated on PAP and then use PAP for 3 months. They will also receive optimized medical preventive therapy according to current American Heart Association guidelines for prevention of CVD and sleep guidelines.
Study: NCT02870478

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine
Description: Dosing frequency comparison, using atropine sulfate 1% solution diluted to 0.01% and 0.05% by Leiter's Compounding Pharmacy
Study: NCT03458013

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Description: Guided using an mp3 player and noise cancelling headphones, participants will be led through a series of mindfulness meditations lasting approximately 20 minutes each.
Study: NCT01086800

Intervention type: OTHER
Group type: OTHER
Intervention: Healthy Lifestyles and Sleep Education plus Supplemental Oxygen
Description: Participants randomized to this arm will be educated on nocturnal supplemental oxygen and then use oxygen for 3 months. They also will receive optimized medical preventive therapy according to current American Heart Association guidelines for prevention of CVD and sleep guidelines.

Intervention type: OTHER
Group type: OTHER
Intervention: Healthy Lifestyles and Sleep Education
Description: Participants randomized to this arm will receive optimized medical preventive therapy according to current American Heart Association guidelines for prevention of CVD and sleep guidelines.
Study: NCT00717938

Intervention type: DRUG
Group type: OTHER
Intervention: cisplatinum or carboplatin and e.g.etoposide.
Description: Standard chemotherapy treatment for patients with small cell lung cancer. Chemotherapy regimen contains a platinum drug and a topoisomerase inhibitor. Numbers of cycles 4-6 according to local variants. Used drugs=cisplatinum or carboplatin and e.g.etoposide. Treatment will be given every three weeks for 4-6 cycles according to local variants.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatinum or carboplatin and e.g.etoposide+enoxaparin
Description: Standard chemotherapy treatment for patients with small cell lung cancer. Chemotherapy regimen contains a platinum drug and a topoisomerase inhibitor. Numbers of cycles 4-6 according to local variants. In addition to this, subjects will receive daily subcutaneous injections of enoxaparin during chemotherapy treatment.
Study: NCT02715037

Intervention type: OTHER
Intervention: Throat swabbing

Intervention type: OTHER
Intervention: Throat swabbing

Intervention type: OTHER
Intervention: Throat swabbing

Intervention type: OTHER
Intervention: Throat swabbing
Study: NCT02890810

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Real Acupuncture with Electrical Stimulation
Description: Acupuncture is a therapy commonly used in East Asian countries, where the practitioner insert thin needles at specific body sites in order to relieve pain and illnesses. Recent studies found low frequency electricity applied through acupuncture needles can lead to profound pain relief by increasing endorphin levels in the central nervous system. Electroacupuncture will thus be used as the active intervention to treat chronic low back pain in this clinical study.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Simulated Acupuncture with Electrical Stimulation
Description: This intervention serves as the placebo control of the active intervention. Sterile acupuncture needles and the ITO electrical stimulators will be used in this intervention. But special care will be taken to have this intervention mimic the real treatment yet remaining as physiologically inert as possible.
Study: NCT01972555

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive aortic valve replacement

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional aortic valve replacement
Study: NCT04802993

Intervention type: OTHER
Intervention: Resection rates
Description: All groups are divided into one high- and one low resection rate group depending on percentage of patients with pancreatic ductal adenocarcinoma resected per county and year (first three groups) and resection rate of pancreaticoduodenectomy per 100 000 inhabitants per county (last three groups)

Intervention type: OTHER
Intervention: Resection rates
Description: All groups are divided into one high- and one low resection rate group depending on percentage of patients with pancreatic ductal adenocarcinoma resected per county and year (first three groups) and resection rate of pancreaticoduodenectomy per 100 000 inhabitants per county (last three groups)

Intervention type: OTHER
Intervention: Resection rates
Description: All groups are divided into one high- and one low resection rate group depending on percentage of patients with pancreatic ductal adenocarcinoma resected per county and year (first three groups) and resection rate of pancreaticoduodenectomy per 100 000 inhabitants per county (last three groups)

Intervention type: OTHER
Intervention: Resection rates
Description: All groups are divided into one high- and one low resection rate group depending on percentage of patients with pancreatic ductal adenocarcinoma resected per county and year (first three groups) and resection rate of pancreaticoduodenectomy per 100 000 inhabitants per county (last three groups)

Intervention type: OTHER
Intervention: Resection rates
Description: All groups are divided into one high- and one low resection rate group depending on percentage of patients with pancreatic ductal adenocarcinoma resected per county and year (first three groups) and resection rate of pancreaticoduodenectomy per 100 000 inhabitants per county (last three groups)

Intervention type: OTHER
Intervention: Resection rates
Description: All groups are divided into one high- and one low resection rate group depending on percentage of patients with pancreatic ductal adenocarcinoma resected per county and year (first three groups) and resection rate of pancreaticoduodenectomy per 100 000 inhabitants per county (last three groups)
Study: NCT02911922

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endorectal Balloon
Description: Endorectal balloon (ERB): Immobilization device manually placed into the rectum prior to radiation treatment planning CT and daily treatment delivery, to immobilize the prostate and reduce prostate motion.~Patients on each arm will receive 5 fractions of radiation, 7.25Gy per fraction, delivered 2-3 times a week (every other day excluding weekends), to total dose of 36.25 Gy. The total duration of treatment will be no shorter than 10 days.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rectal Spacer
Description: Rectal spacer (RS): Biodegradable gel that is transperineally injected between the rectum and prostate under transrectal ultrasound guidance, to increase physical distance and thereby reduce radiation dose to the anterior rectal wall. The spacer begins to biodegrade in 2-3 months, and is fully absorbed within 6 months.~Patients on each arm will receive 5 fractions of radiation, 7.25Gy per fraction, delivered 2-3 times a week (every other day excluding weekends), to total dose of 36.25 Gy. The total duration of treatment will be no shorter than 10 days.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: Patients on each arm will receive 5 fractions of radiation, 7.25Gy per fraction, delivered 2-3 times a week (every other day excluding weekends), to total dose of 36.25 Gy. The total duration of treatment will be no shorter than 10 days.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: Patients on each arm will receive 5 fractions of radiation, 7.25Gy per fraction, delivered 2-3 times a week (every other day excluding weekends), to total dose of 36.25 Gy. The total duration of treatment will be no shorter than 10 days.
Study: NCT03033355

Intervention type: DRUG
Intervention: Intradetrusor injection of Botulinum Toxin-A
Description: Using cystoscopy, Botulinum Toxin-A is injected into the bladder.
Study: NCT03739632

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hypidone Hydrochloride tablets
Description: Hypidone Hydrochloride tablets will be given orally, twice daily, for 6 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hypidone Hydrochloride tablets
Description: Hypidone Hydrochloride tablets will be given orally, twice daily, for 6 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hypidone Hydrochloride tablets
Description: Hypidone Hydrochloride tablets will be given orally, twice daily, for 6 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets will be given orally, twice daily, for 6 weeks
Study: NCT02195388

Intervention type: OTHER
Intervention: comprehensive cardiac rehabilitation
Description: Standard program of comprehensive cardiac rehabilitation CR with physical activity, behavioral intervention, risk factor modification and intervention.

Intervention type: OTHER
Intervention: comprehensive cardiac rehabilitation
Description: Standard program of comprehensive cardiac rehabilitation CR with physical activity, behavioral intervention, risk factor modification and intervention.
Study: NCT00993928

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based sleep intervention
Description: Participants will be asked to practice behaviors consistent with the stimulus control sheet and to read the sleep hygiene booklet.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home-based sleep intervention
Description: Participants will be asked to practice behaviors consistent with the stimulus control sheet and to read the sleep hygiene booklet.
Study: NCT01359475

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acetal crown, LD Caulk ltd, USA
Description: Experimental trial of preformed acetal crowns for primary molars
Study: NCT02774837

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil
Description: Tenofovir disoproxil 300mg once daily for 96 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tenofovir disoproxil
Description: Tenofovir disoproxil 300mg once daily for 96 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telbivudine
Description: Telbivudine oral tablets 600mg once daily for 96 weeks
Study: NCT04627272

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AutoDX-DR
Description: AutoDx-DR provides basic image interpretation for the detection of DR and diabetic macular edema (DME) and a Refer or Not Refer recommendation.
Study: NCT00005613

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Cyclophosphamide will be given at a dose of 1500 mg/m2/day IV over 1.0 hour on days -6, -5, -4, and -3.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Cyclophosphamide will be given at a dose of 1500 mg/m2/day IV over 1.0 hour on days -6, -5, -4, and -3.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Description: Etoposide will be given at a dose of 600 mg/m2/day over 3.0 hours on days -6, -5, and -4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Description: Etoposide will be given at a dose of 600 mg/m2/day over 3.0 hours on days -6, -5, and -4.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BCNU
Description: BCNU will be given at a dose of 150 mg/m2/day in 500 cc D5W over 3.0 hours on days -6, -5, and -4

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BCNU
Description: BCNU will be given at a dose of 150 mg/m2/day in 500 cc D5W over 3.0 hours on days -6, -5, and -4
Study: NCT03253341

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smart Aging Program
Description: Comprehensive lifestyle and fitness program designed to improve the health of older adults. The Smart Aging Program represents a package consisting of a dedicated health coach, mobile monitoring, specialized curriculum, and exercise opportunities.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational Materials
Description: Current standard of care. Includes education materials covering benefits of a healthy lifestyle.
Study: NCT01900418

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Walk with Ease
Description: An evidence-based walking program
Study: NCT01871740

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enalapril maleate and folic acid tablets
Description: Enalapril maleate and folic acid tablets, (10mg/0.8mg)/tablet, taken orally and once daily for a maximum of 5 years. Combination with other anti-hypertension drugs are allowed.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enalapril maleate
Description: Enalapril, 10mg/tablet, taken orally once daily for a maximum of 5 consecutive years. Combination with other anti-hypertension drugs are allowed.
Study: NCT04483388

Intervention type: OTHER
Group type: OTHER
Intervention: Training with Virtual Reality
Description: Computed virtual reality therapy was performed using the Nintendo Wii® console equipment. This system allows interaction with the player by means of a movement detection system and the representation of his avatar graphical representation of a user in virtual reality. It has a remote control with a wireless system, responsible for capturing the speed, direction , acceleration and deceleration of movement. The movements performed by the player are captured and reproduced on a screen via an infrared light sensor, positioned above the TV. The feedback given by the TV provides the movement itself observing opportunity in real time, generating positive reinforcement and facilitating training and improved task. The software used in this study was the Nintendo Wii Sports.

Intervention type: OTHER
Group type: OTHER
Intervention: Training with Virtual Reality
Description: Computed virtual reality therapy was performed using the Nintendo Wii® console equipment. This system allows interaction with the player by means of a movement detection system and the representation of his avatar graphical representation of a user in virtual reality. It has a remote control with a wireless system, responsible for capturing the speed, direction , acceleration and deceleration of movement. The movements performed by the player are captured and reproduced on a screen via an infrared light sensor, positioned above the TV. The feedback given by the TV provides the movement itself observing opportunity in real time, generating positive reinforcement and facilitating training and improved task. The software used in this study was the Nintendo Wii Sports.

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Training
Description: It was done five types of exercises following to the protocol:~Exercise 1 (shoulder abduction); Exercise 2 (external rotation of the shoulder); Exercise 3 (elbow extension); Exercise 4 (weight transfer in upper limbs: a sitting position); Exercise 5 (function: task-oriented training).

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Training
Description: It was done five types of exercises following to the protocol:~Exercise 1 (shoulder abduction); Exercise 2 (external rotation of the shoulder); Exercise 3 (elbow extension); Exercise 4 (weight transfer in upper limbs: a sitting position); Exercise 5 (function: task-oriented training).
Study: NCT02086396

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: pumpkin seed flour
Description: The pumpkin seed flour group received 20g/day of pumpkin seed flour during 12 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (cassava flavored flour)
Description: The group placebo (cassava flour flavored) received 20g/day of cassava flour flavored during 12 weeks.
Study: NCT01698034

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Volunteering
Description: Weekly volunteering with elementary school children in after school programs